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Abstract 
Considerable work is being carried out on uNK cells to determine their role in 
pregnancy outcome. There is also debate about whether uNK cell measurements 
should be included in the clinical assessment for women with reproductive failure.  
The fact that the density of uNK cells reported by different centres varies makes 30 
advances in this field difficult. The aim of this study was to determine the reason for 
these differences and to develop a standardised method. Three centres exchanged 
five sections of endometrium from five women. Sections were immunostained for 
CD56.  Images were taken of 10 random fields at x400 magnification; total stromal 
and uNK cells were counted using Image J.  Results were expressed as % positive 35 
uNK cells and the variation in counts obtained in each centre was compared. After 
initial analysis a standardised protocol was agreed and the process repeated. 
Significant variation was seen in the counts obtained after initial analysis (Centre 
AvsB, mean difference = -0.72 P<0.001; AvsC mean difference = -0.47 P<0.001; 
BvsC, mean difference = 0.25 P=0.085).  Differences may be due to duration of 40 
fixation, the embedding and sectioning processes, selection of areas for assessment, 
definition of immunopositive cells and inclusion or exclusion of blood vessels. 
Adoption of a standardised protocol reduced the variation (Centre AvsB mean 
difference = -0.105 P=0.744; AvsC mean difference = 0.219 P=0.150; BvsC mean 
difference = 0.32 P=0.031). Use of a standardised method is needed to develop a 45 
meaningful clinical test for uNK cell measurements. 
 
 
 
 50 
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Introduction   
Uterine natural killer (uNK) cells are the major leucocyte present in the endometrium 55 
at the time of implantation and early placentation.  They differ phenotypically from 
most peripheral blood NK cells and are CD56bright, CD16-, CD9+ with cytolytic 
granules and increased KIR expression (Bulmer et al. 2010 Male et al. 2011).  
Although peripheral blood also contains a subpopulation (10%) of phenotypically 
similar cells, microarray analysis has shown that the CD56bright CD16- NK cells in 60 
peripheral blood are distinct from uNK cells (Koopman et al. 2003).  CD56+ cells are 
present throughout the menstrual cycle but the number increases exponentially in 
the mid-secretory phase starting 6 to 7 days after the LH surge, the beginning of the 
putative time of implantation.  The number of CD56+ cells remains high during early 
pregnancy and comprises 70% of the lymphocytes at the interface between maternal 65 
decidua and the invading trophoblast (Bulmer & Lash 2005).  The exact function of 
uNK cells is unclear, although their increased numbers at the time of embryo 
implantation and their presence adjacent to the invading trophoblast suggests that 
they play a role in implantation.  Unlike peripheral blood NK cells, uNK cells in 
endometrium have lower cytolytic activity and increased cytokine production (Bulmer 70 
& Lash 2005).  More recent work suggests that uNK cells produce numerous 
angiogenic factors and may play a role in spiral artery remodelling which is essential 
for establishing a successful pregnancy (Li et al. 2001; Lash et al. 2010; Robson et 
al. 2012). 
 75 
The numbers of uNK cells are increased in the peri-implantation endometrium of a 
sub-population of women with recurrent miscarriage (RM) (Quenby et al. 1999; 
Clifford et al. 1999; Tuckerman et al. 2007) and women with recurrent implantation 
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failure after IVF (RIF) (Ledee-Bataille et al. 2004; Tuckerman et al. 2010), which 
suggests that they may play an important role in embryo implantation.  However, 80 
there are contradictory reports as to whether an increased number of endometrial 
uNK cells correlates with pregnancy outcome in these women (Tuckerman et al 2010; 
Tang et al. 2011). This is in part due to a lack of understanding of the role of uNK 
cells in the establishment of pregnancy and therefore how their altered numbers may 
impact reproductive health. Despite this controversy there is an increasing demand 85 
from women with recurrent reproductive failure for an "endometrial uNK cell count 
test".  However, even if the result shows a high number of uNK cells there are no 
proven successful treatments, although treatment with prednisolone has been shown 
to have some success in one centre (Quenby et al. 2005; Lash et al. 2011).  All this 
has led to debate about whether measurements of uNK cells should be included in 90 
clinical assessment for women with RIF or RM (Sacks 2015; Moffett & Shreeve 
2015). 
 
One of the difficulties in advancing this area is the lack of consensus in reporting 
uNK cell number and in particular in defining what constitutes a "high" uNK cell count; 95 
one centre has used a cut off of 5% (Quenby et al. 2005), while another has used a 
cut off of 12.9% (Tuckerman et al. 2010).  There is also no clear definition of a 
"normal range" of uNK cell numbers, partly because obtaining endometrium from 
normal fertile control women is difficult.  In addition, for practical reasons many 
centres sample over a 3 day period (LH+6-LH+8 or LH+7-LH+9), but during this time 100 
period uNK cell numbers increase exponentially (Russell et al. 2011; Russell et al. 
2013), which may skew clinical results dependent on the “reference range” being 
used.   
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In order to understand further the role of uNK cells in successful pregnancy outcome 105 
and to provide patients with a meaningful clinical test, a single methodological 
protocol for measurement of endometrial uNK cells is needed.  The aim of this study 
was to explore why different centres report such differences in uNK cell numbers, 
despite apparently using the same immunostaining methodology, to develop a 
standardised protocol and to test whether the application of this protocol reduced the 110 
variation between centres.  Until standard methodology for assessment of uNK cells 
is established the question of variation related to biopsy timing cannot be addressed. 
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Materials and methods 
Study design and tissue samples 115 
Three different centres in the UK took part in this study; Reproductive and Vascular 
Biology Group, Institute of Cellular Medicine, Newcastle University (Centre A); 
Sheffield Hallam University and Jessop Wing, Sheffield Teaching Hospitals (Centre 
B) and Biomedical Research Unit in Reproductive Health, Warwick University 
(Centre C).  Local ethical committee approval was obtained for the collection of 120 
samples, and informed consent was obtained from each patient.  Each centre 
provided 5 x 3µm formalin fixed paraffin embedded sections cut from endometrial 
tissue from five different patients. Samples from Centre A were collected from 
women undergoing hysterectomy for non-malignant conditions not affecting the 
endometrium and were collected at random times during the menstrual cycle.  125 
Samples from Centre B were from women with recurrent implantation failure after 
IVF (RIF) and were collected on LH+7-LH+9 of the cycle.  Samples from Centre C 
were collected from women with recurrent miscarriage (RM) and were collected on 
days LH+6-LH+8.  Each centre immunostained the 15 samples and counted the 
number of cells using their "usual" research or routine Pathology Department 130 
procedure as detailed below.  The results obtained for each of the 15 samples in 
each of the centres were compared.  After a review and discussion to identify 
reasons for the differences observed a standardised protocol was developed; the 
process was then repeated on a further 15 freshly collected samples (five from each 
centre) using the agreed protocol.  135 
 
 
 
8 
 
Initial analysis 
The processing of tissue and staining of CD56+ cells in the initial experiment was 140 
carried out as per the established procedure in each centre detailed below 
(Tuckerman et al 2007; Tuckerman et al 2010; Quenby et al. 2005; Lash et al. 2012). 
In addition to their usual procedure Centre A assessed differences in slides stained 
in the routine pathology laboratory and use of a different second antibody system. 
 145 
Centre A 
Samples (biopsies from hysterectomy specimens) were fixed in 10% buffered 
formalin for 24-48 hours at room temperature prior to routine processing, embedding 
in paraffin wax and microtome sectioning (3μm thick sections).  Immunostaining was 
performed within the routine Cellular Pathology laboratory (automated staining using 150 
the Ventana XT staining platform (Ventana Medical Systems, Basel, Switzerland)) 
and in the research laboratory (hand stained using two different detection systems, 
Vectastain Elite ABC kit (Vector Laboratories, Peterborough, UK) and Expose kit 
(AbCam, Cambridge, UK)).  In the research laboratory sections were dewaxed in 
xylene, rehydrated through descending concentrations of alcohol to 0.15M Tris 155 
buffered 0.05M saline, pH 7.6 (TBS), incubated in 1% H2O2 in methanol for 10 min to 
block endogenous peroxidase activity and subjected to heat-mediated unmasking of 
antigen by pressure cooking in citrate buffer, pH 6.0 for 1 min.  The sections were 
then incubated in anti-CD56 antibody (NCL-CD56-504; 1:100 dilution; Leica 
Biosystems, Newcastle upon Tyne, UK) at room temperature for 1 hour before 160 
detection with the appropriate secondary kit (as described above) and visualised 
using 3,3'-diaminobenzidine (DAB; Sigma Chemical Co., Poole, UK) containing 0.01% 
H2O2 to give a brown reaction product.  The sections were lightly counterstained with 
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Mayer´s haematoxylin, dehydrated, cleared in xylene and mounted with DPX 
(distrene, plasticiser, xylene) synthetic resin (Raymond A. Lamb Ltd., London, UK).  165 
Negative controls included replacement of the primary antibody by appropriate non-
immune serum and were performed for each antibody run.  In the routine pathology 
laboratory staining was performed using the Ventana automated staining system (all 
reagents being from Ventana Medical Systems).  Antigen retrieval was performed 
using solution CC1 for 60 min, the primary antibody used was anti-CD56 (123C3; 170 
predilute) and the detection system was Ultraview DAB kit (760-500).  
 
Image analysis was performed by one operator who imaged 10 x400 fields using a 
Nikon 80i microscope and NIS Elements software (Nikon Instruments Inc., Surrey, 
UK).  Random images were taken with the luminal epithelium in view, moving 1 field 175 
of view away between each image, and cell counts were performed using Image J 
(Version 1.46, NIH, Maryland, USA) cell counter plug in.  The total number of stromal 
cells was determined by counting the number of nuclei, and the total number of uNK 
cells determined by counting immunopositive cells.  Luminal and glandular 
epithelium were not included in the total stromal cell count, but blood vessels were.  180 
Data are expressed as %uNK cells/total stromal cells. 
 
Centre B 
Samples (endometrial pipelle biopsies) were fixed in 10% buffered formalin for 24-48 
hours at room temperature prior to routine processing, embedding in paraffin wax 185 
and microtome sectioning (3μm thick sections).  Immunostaining was performed 
within the research laboratory where sections were dewaxed in xylene, rehydrated 
through alcohols to TBS and incubated in 3% H2O2 in methanol for 20 min to block 
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endogenous peroxidase activity.  Heat-mediated unmasking of antigen was 
performed by microwaving (800W) in citrate buffer, pH 6.0.  Buffer was heated in the 190 
microwave oven until boiling, slides were added to the buffer and incubated on high 
for 3 min, followed by 12 min on medium and then allowed to cool for 20 min.  The 
sections were then incubated in anti-CD56 antibody (NCL-CD56-504; 1:50 dilution; 
Leica Biosystems) at room temperature for 1 hour and then at 4°C overnight before 
detection with the Vectastain Elite ABC kit (Vector Laboratories) and DAB containing 195 
0.01% H2O2 (Vector Laboratories).  The sections were lightly counterstained with 
Mayer´s haematoxylin, dehydrated, cleared in xylene and mounted with DPX 
synthetic resin (Sigma Chemical Co.).   
 
Image analysis was performed by one operator who assessed 10 x400 fields directly 200 
using an Olympus BX60 microscope (Olympus Keymed, Essex, UK).  Fields of view 
were chosen at random throughout the tissue with the total number of stromal cells 
determined by counting the number of nuclei, and the total number of uNK cells 
determined by counting immunopositive cells.  Luminal and glandular epithelium, 
and blood vessels were not included in the total stromal cell count.  Data are 205 
expressed as %uNK cells/total stromal cells. After initial comparison of data and 
discussion between the operators in the 3 centres, Centre B reanalysed this initial 
set of slides.  Images were taken with the luminal epithelium in view and cell counts 
were performed using Image J (Version 1.46, NIH) cell counter plug in.   
 210 
Centre C 
Samples (endometrial pipelle biopsies) were fixed in 10% buffered formalin for 24-
120 hours at room temperature prior to routine processing, embedding in paraffin 
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wax and microtome sectioning (3μm thick sections).  Immunostaining was performed 
within the routine pathology laboratory (automated staining using the Bondmax 215 
automated staining station and associated solutions (Leica Biosystems)).  Antigen 
retrieval was performed by pressure cooking in citrate buffer, pH 6.0 for 1 min.  The 
primary antibody used was anti-CD56 (NCL-CD56-504; 1:200 dilution) and the 
detection system was the Novocastra Bond Polymer Refine Detection kit.  
 220 
Image analysis was performed by one operator.  The slides were scanned using the 
MIRAX Midi Digital Slide Scanner (Carl Zeiss MicroImaging GmbH, Jena, Germany). 
The images were viewed using ‘Panoramic Viewer’ (3D HISTECH Ltd, Budapest, 
Hungary) and 10 x400 fields were assessed.  Images were taken with the luminal 
epithelium in view and cell counts were performed using Image J (Version 1.46, NIH) 225 
cell counter plug in.  The total number of stromal cells was determined by counting 
the number of nuclei, and the total number of uNK cells determined by counting 
immunopositive cells.  Luminal and glandular epithelium were not included in the 
total stromal cell count, but blood vessels were.  Data are expressed as %uNK 
cells/total stromal cells. 230 
 
Standardisation analysis 
Inter-observer error was determined by swapping images between Centre A and 
Centre B (n=13 total), each being assessed by 3 different operators (1 from Centre A 
and 2 from Centre B). 235 
 
To determine the optimal number of total stromal cells to count, running averages 
assessment was performed (n=14).  The %uNK cells/stromal cells in10 
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images/sample were determined, the mean obtained, and from this value 5% of the 
mean was calculated.  A running average was determined by calculating the mean of 240 
images 1+2, 1+2+3, etc until the values fell within the 5% of the mean of the 10 
images.  The number of images and total stromal cells to reach this level of 
consistency was then determined (Mariee et al. 2012). 
 
In some cases insufficient luminal epithelium was available to perform all necessary 245 
assessments at this level in the tissue.  From the initial analysis and discussions we 
were aware that assessment of cells in the deeper endometrium gave spurious high 
results.  We therefore aimed to determine how far from the luminal edge we could 
assess while still obtaining consistent results.  To this end 10 samples were chosen 
and 4-5 x400 consecutive images from the luminal edge were obtained and 250 
assessed as described above for Centre A. 
 
Development of an agreed protocol  
Several meetings were held between the participants from the different centres to 
discuss the sources of variation; a standardised protocol was then developed for 255 
further testing.  Using our collective experience and after comparison of each 
centre's original methodology it was agreed that sources of variation arose from 
quality of tissue fixation (including excessively long fixation), processing, image 
capture, selection of areas to count, and definition of immunopositive cells.  To test 
all of these potential sources of variation individually would have required a large 260 
number of additional samples and therefore the decision was taken to alter all of 
these potential sources of variation.  Figure 1 shows the standard procedure adopted 
as a result of these discussions.   
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The amended protocol included fixation of the tissue in neutral buffered formalin for 265 
24-48 hours at room temperature and ensuring that water baths used during 
sectioning were kept dust free.  The immunostaining was carried out as described 
above for each centre, with Centre A using the Vectastain Elite ABC kit in the 
research laboratory.  Images for analysis were selected adjacent to the luminal edge, 
or as close as possible within 5 fields, and captured digitally.  Cells were counted 270 
using the cell counter plug in in Image J, with at least 3800 total stromal cells 
counted.  All stromal cells were counted, including endothelial cells and smooth 
muscle cells of the blood vessels, but excluding glandular and luminal epithelium.  
The % uNK cells/total stromal cells for each image was calculated; the final cell 
count was reported as the mean of all counted images.   275 
 
Statistical analysis 
Data are presented as means + SD. Agreement between the counts obtained by 
each centre, by each of the three different methods within one centre and between 
single operators was assessed using a linear mixed effects model (Roy 2009). Since 280 
the counts were not normally distributed the logit-transform of the proportion of 
positive cell counts were used for the analysis. Analyses were conducted using the 
nlme package in the R statistical software package.  P<0.05 was considered 
significantly different.  
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Results  285 
Variation in uNK cell numbers after initial assessment 
One of the samples provided by Centre A for the initial analysis did not contain a 
luminal epithelial border and therefore was not included in the analysis, leaving n=14 
for this part of the study.  Mean (± SD) of cell counts for each sample assessed 
under all conditions by each of the different centres is shown in Table 1. 290 
 
There was considerable variation in the % CD56+/total stromal cells within the same 
endometrial biopsy sample reported from each centre after the initial analysis (Table 
1 and Figure 2A).  This was explained, at least in part, by the fact that one of the 
centres (Centre B) did not use Image J for cell counting, assessing slides manually 295 
and also did not always count cells adjacent to the luminal epithelial edge.  This 
centre then re-analysed the slides that they had stained using Image J making sure 
that a luminal edge was included in all fields.  This reduced, but did not eliminate the 
variation (Figure 2B). Significant variation was still seen in the counts obtained 
(Centre A vs. B, mean difference = -0.72 P<0.001; A vs. C mean difference = - 0.47 300 
P<0.001; B vs. C, mean difference = 0.25 P=0.085).   
 
Figure 3 illustrates the differences in immunostaining patterns obtained from each 
centre on slides provided by the three different centres.  Tissue processed in Centre 
A showed clear positive immunostaining around the periphery of the cells, while 305 
samples processed in the other two centres showed additional specks of positive 
immunostaining that were not associated with cell nuclei.  These observations were 
irrespective of which centre performed the immunostaining and therefore suggested 
an issue in the fixation, processing and section preparation processes. 
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Variation between staining methods and assessment operator 310 
The variation in % CD56+ cells obtained in Centre A when the analysis was carried 
out in the routine pathology laboratory and in the research setting using two different 
secondary antibody systems (Vectorstain Elite ABC or the Expose kit) was also 
assessed.  Although there were differences in the number of positive cells reported, 
the variation was considerably less than the variation between the three centres 315 
(Expose vs. ABC, mean difference = -0.025 P=0.678; Expose vs. Routine Pathology, 
mean difference = 0.15 P=0.026; ABC vs. Routine, mean difference = -0.18 P=0.004) 
(Figure 4A). 
 
There was also some evidence for variation in the counts obtained when the same 320 
image was counted by 3 different observers (n=13), although the magnitude was not 
as large as between centre variation (Operator 1 vs. Operator 2 mean difference = 
0.355 p=0.019; Operator 1 vs. Operator 3 mean difference = 0.089 P=0.315; 
Operator 2 vs. Operator 3 mean difference = -0.266 P = 0.0265) (Figure 4B).  
 325 
Numbers of fields/cells to be counted 
 
The distribution of uNK cells within the tissue is not uniform. In addition despite all 
sections being photographed at x400 magnification, the images appeared to show 
different degrees of magnification (Figure 3).  This was due to different microscope 330 
camera systems with different magnifications or ‘camera factors’.  To determine the 
total number of cells that need to be counted to overcome both these issues we used 
the running average method (Mariee et al. 2012) to determine that 3800 stromal cells 
needed to be counted to provide a true and reliable cell count (Figure 4C). 
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 Depth of field for analysis 335 
Not all samples contained sufficient luminal epithelium for 10 adjacent x400 fields or 
3800 total stromal cells to be included. Given that samples from patients suffering 
reproductive failure are likely to be pipelle biopsies this could present a problem in 
the clinical situation.  To determine the effect of depth from luminal surface on the 
fields chosen for counting, individual x400 fields were chosen up to 5 x400 fields 340 
from the endometrial luminal edge as shown in Figure 5A.  The number of cells was 
similar when fields were chosen up to 4 fields away from the luminal edge (Figure 
5B).   
 
Implementation of standardised protocol 345 
Fifteen new samples (5 from each centre) were processed, stained and counted 
using the agreed protocol (Figure 1).  Two of the samples provided by Centre A did 
not contain a luminal epithelial border and were not included in the analysis, leaving 
n=13 for this part of the study.  Mean (± SD) for all samples assessed in each of the 
different centres is shown in Table 2. Reduced variation was seen in the counts 350 
obtained (Centre A vs. B mean difference = -0.105 P=0.744; A vs. C mean difference 
= 0.219 P=0.150; B vs. C mean difference = 0.32 P=0.031 (Figure 6A).  In addition, 
images taken in each centre of the different centre's samples were more similar to 
each other (Figure 6B) compared with the initial assessment (Figure 3). 
  355 
17 
 
Discussion and Conclusion 
There is considerable evidence that uNK cells may play a role in successful embryo 
implantation, formation of the placenta, control of trophoblast invasion and spiral 
artery transformation and therefore pregnancy outcome (Lash et al. 2010; Moffatt-
King 2002).  However, advancement in our understanding of this mechanism and 360 
how measurement of endometrial uNK cell numbers may be used clinically is 
hindered by a lack of consistency between numbers of cells reported between 
centres and a clear definition of the ‘normal’ range for endometrial uNK cells.  The 
normal range of endometrial NK cells needs to be determined before its clinical 
application to patients with poor reproductive outcomes; sampling of endometrium 365 
from normal fertile control women is possible, but if methodologies result in different 
reported values from site to site the normal range cannot be established. 
 
In this study we have investigated why three different centres in the UK report very 
different endometrial NK cell numbers, despite apparently using the same 370 
immunohistochemical method to identify positive cells. Each centre stained five 
sections provided by each of the three centres and counted the cells according to 
their original protocol. The results were discussed and a strict protocol developed to 
try and eliminate variation. Sample processing, staining and counting was then 
repeated taking into account the new protocol. The variation in the counts reported 375 
for each sample was reduced substantially.  We were not able to change each 
parameter individually and therefore cannot pinpoint the exact source of the variation 
in the original analysis, but the difference in appearance of sections prepared from 
tissue collected and processed in the 3 different centres suggest that it may be due 
to duration of tissue fixation, differences in the wax embedding or sectioning 380 
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processes. To eliminate the variation in tissue processing the samples were fixed in 
10% neutral buffered formalin for 24-48 hours at room temperature and processed 
conventionally with xylene.  
 
One of the factors identified as contributing to the variation was the fact that one 385 
centre was not counting cells adjacent to the luminal edge, but instead was choosing 
fields at random across the tissue.  The distribution of leucocytes within the 
endometrium is not uniform; there is clustering of leucocytes, including CD56+ cells, 
particularly around glands and blood vessels (Bulmer & Lash 2005). This is also the 
reason for the sometimes quite considerable variation in the counts obtained for 390 
each field in an individual sample. To obtain consistent results it was calculated that 
at least 3800 stromal cells need to be counted; this agrees with previously published 
work (Mariee et al. 2012).  Expressing this parameter as a cell number rather than a 
number of fields is necessary to overcome the camera factors associated with 
different microscope and digital camera systems. 395 
 
The method used to select fields for counting was discussed extensively.  Previously 
the fields for counting were chosen ‘at random’ across the tissue.  However, to be 
truly ‘random’ in selection of fields for quantification is extremely difficult and there is 
a tendency to choose fields where there are positive cells and ignore fields where all 400 
cells are negative.  In order to prevent observers only counting fields that contained 
positive cells the first field to be captured was selected at random, ensuring that it 
contained the luminal epithelial border.  Subsequent fields were obtained by moving 
one field to the left or right of the original field (skipping a field between each 
captured image), keeping the luminal epithelial border in view and repeated until 10 405 
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fields had been captured.  If there were not 10 fields containing the luminal 
epithelium in view, we have demonstrated that using up to 4 consecutive fields 
extending deeper into the tissue will still provide valid results. 
 
Variation also arose from definition of an immunopositive cell; with some observers 410 
counting brown staining not associated with a cell nucleus, it was therefore 
recommended that a cell nucleus must be visualised with the immunopositive 
membrane staining to assess a cell as positive. Another issue was the counting of 
cells around blood vessels, with some assessors not including this compartment in 
their cell counts.  However, it is not always easy to distinguish these cells from the 415 
stromal population, especially if the vessel has poorly developed muscle layers.  For 
a protocol to be successful it needs to simple and easy to use and therefore it was 
decided that cells across the whole of the stromal compartment should be included, 
although luminal and glandular epithelial cells, which are easily distinguished are 
excluded.   420 
 
One of the limitations of the study is the sample size (five samples from 3 different 
centres - 15 samples in total). However, the aim of this study was simply to 
determine why reports of uNK cell counts are so different and to identify the key 
steps or factors which are important in preventing this happening in the future. This 425 
sample size was large enough to achieve this and will enable further work, using 
larger numbers to take these factors into account. 
 
Numbers of uNK cells increase exponentially as the menstrual cycle progresses 
(Bulmer & Lash 2005; Russell et al. 2011; Russell et al. 2013) and therefore timing of 430 
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the biopsy is critical or a reference range of ‘normal’ uNK cell numbers throughout 
the menstrual cycle needs to be established.  However, before this can be 
addressed a method which provides consistency between different centres is 
required and this study has addressed this.  Further work is required to determine 
what constitutes a ‘high’ uNK cell density and the timing of the biopsy will be an 435 
important aspect of this work.  In addition, it still needs to be determined whether the 
increased uNK cell numbers reflects a causative role in recurrent miscarriage and 
recurrent implantation failure or rather is a marker of a more generalised endometrial 
dysfunction that contributes to these conditions (Salker et al. 2010; Teklenburg et al. 
2010).   440 
 
Conclusion 
This study shows the importance of bringing quality control processes into the 
measurement of uNK cells and the need to establish a quality control methodology 
prior to extension to clinical practice.  The method described in this paper may not be 445 
perfect, but it is producing consistent results and will enable comparison of results 
between centres.  A larger sample size and the inclusion of different laboratories is 
now required to fully refine and validate this protocol; of particular interest will be 
further definition of the field of view selected for assessment.  In addition, 
standardized collection and assessment of samples from normal fertile control 450 
women will enable us to establish a "normal" range for endometrial uNK cells and to 
determine their role in implantation.  
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Table 1. Initial assessment (Mean + SD) 
 
 460 
 
 
 
 
 465 
 
 
 
 
 470 
 
 
 
 
 Centre A – 
Expose kit 
Centre A – 
ABC Vector kit 
Centre A – Routine 
Pathology 
Centre B – 
Manual 
Centre B – 
Image J 
Centre C 
A 4.7 ± 1.5 3.9 ± 1.4 2.3 ± 0.8 24.9 ± 6.7 12.2 ±2.7 12.6 ± 1.6 
B 5.8 ± 2.3 4.4 ± 1.3 4.1 ± 0.9 27.4 ± 5.9 14.0 ± 5.6 9.8 ± 0.5 
C 2.2 ± 0.9 3.3 ± 1.6 2.0 ± 0.9 26.4 ± 12.5 6.2 ± 3.1 4.5 ± 0.2 
D 3.2 ± 0.2 3.7 ± 1.2 3.6 ± 0.2 8.9 ± 2.4 6.9 ± 1.8 4.5 ± 0.8 
E 5.1 ± 2.2 5.2 ± 2.5 5.8 ± 2.5 13.1 ± 6.2 24.6 ± 10.2 7.7 ± 0.8 
F 2.0 ± 0.7 2.7 ± 1.4 2.0 ± 1.1 4.7 ± 2.2 1.9 ± 1.2 3.2 ± 0.06 
G 9.8 ± 2.9 9.1 ± 2.6 8.9 ± 2.1 18.0 ± 5.1 20.1 ± 7.9 13.1 ± 0.9 
H 4.3 ± 2.1 4.4 ± 1.6 3.8 ± 1.0 10.5 ± 4.6 8.7 ± 3.8 4.4 ± 0.8 
I 6.8 ± 1.4 9.8 ± 2.0 7.0 ± 2.7 22.0 ± 9.1 15.3 ± 5.4 17.4 ± 1.1 
J 5.3+1.9 5.3+2.2 5.3+1.7 14+2.8 10.6+5.3 10.2+0.8 
K 2.0+1.6 2.1+0.6 1.8+0.9 5.7+1.7 2.5+0.8 2.8+0.2 
L 27.8 + 5.3 30.8 ± 5.7 25.4 ± 3.6 37.0 ± 4.7 38.8 ± 5.3 24.5 ± 3.9 
M 1.5 ± 0.6 1.5 ± 0.8 1.7 ± 0.4 6.5 ± 1.4 3.0 ± 1.7 2.2 ± 0.1 
N 1.7 ± 0.5 1.3 ± 0.5 0.9 ± 0.5 3.7 ± 2.0 2.5 ± 1.5 1.8 ± 0.07 
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Table 2. Validation assessment (Mean + SD) 475 
 Centre A Centre B Centre C 
A 4.8 + 9 4.5 + 0.7 3.7 + 0.7 
B 6.5 + 0.7 3.4 + 0.3 4.6 + 0.3 
C 2.9 + 0.6 4.5 + 0.4 3.8 + 0.3 
D 6.5 + 0.6 3.5 + 0.5 3.3 + 0.2 
E 5.7 + 0.5 2.2 + 0.2 1.8 + 0.3 
F 9.8 + 0.7 6.6 + 0.6 7.2 + 0.9 
G 2.4 + 0.4 3.0 + 0.9 1.4 + 0.2 
H 1.7 + 0.4 1.1 + 0.3 1.0 + 0.3 
I 13.1 + 1 13.3 + 1.4 15.1+ 0.6 
J 2.7 + 0.4 2.2 + 0.5 2.0 + 0.2 
K 16.7 + 2.2 22.7 + 1.8 12.6 + 1.8 
L 2.5 + 0.2 3.8 + 0.6 3.8 + 0.2 
M 1.4 + 0.3 2.2 + 0.5 0.6 + 0.1 
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Figure legends 555 
Figure 1: Schematic of the standardised protocol. 
Figure 2:  Comparison of % CD56+ cells reported for the same samples from each 
of the different centres.  A) Initial analysis.   B) After re-analysis by Centre B using 
Image J and inclusion of the luminal edge.   
Figure 3:  Photomicrographs showing differences in staining obtained when staining 560 
was carried out in one centre on samples processed at the three different centres (A). 
B) Higher magnification photomicrographs to demonstrate immunopositive uNK cells 
(left) and specks of brown DAB reactivity not fully associated with a cell nucleus 
(right). 
Figure 4:  Comparison of % CD56+ cells in the different samples when A) analysed 565 
by three different methods (Expose polymer based kit, Abcam; ABC Vector kit, 
Vector laboratories; Routine Cellular Pathology laboratory, Ventana Medical 
Systems) in the same centre, and counted by the same operator and B) three 
different operators assessed the same images.  C) Representative graph of running 
averages to determine the total number of stromal cells to count to achieve 570 
consistent results. 
Figure 5: The effect of counting cells in fields further away from the endometrial 
luminal edge.  A) Illustrates how the fields can be chosen in one particular sample.  
B) shows the % CD56+ cells in each field up to 4 or 5 deep to the luminal edge 
(n=10 different samples). 575 
Figure 6:  A) Comparison of % CD56+ cells reported for the same samples from 
each of the different centres after adopting the agreed protocol. B) 
Photomicrographs showing reduced visible differences (compared with Figure 3) in 
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staining obtained when staining was carried out in one centre on samples processed 
at the three different centres. 580 
